Literature DB >> 32067411

Prevalence and causes of infantile nystagmus in a large population-based Danish cohort.

Karen Hvid1, Kamilla Rothe Nissen1, Allan Bayat2,3, Laura Roos4, Karen Grønskov4, Line Kessel1,5.   

Abstract

PURPOSE: The aim of this study was to provide a population-based estimate on the prevalence of infantile nystagmus and to describe the causes in the Capital Region of Denmark.
METHODS: Review of medical records of children with infantile nystagmus born in the period 1 January 2010 through 31 December 2017 and living in the Capital Region of Denmark. We used birth registry data from Statistics Denmark and the National Danish Birth Registry to calculate the prevalence of nystagmus in children born at term and prematurely.
RESULTS: A total of 103 patients (52 males/51 females) with infantile nystagmus were included. The overall prevalence of infantile nystagmus was 6.1 per 10 000 live births. It was higher in premature children (28.4/10 000 live births) than children born at term (4.4/10 000), p < 0.0001, and highest in children born extremely preterm, (97.3/10 000). The most common cause of infantile nystagmus was ocular disease (44%) followed by idiopathic nystagmus (32%), neurological disorders and genetic syndromes (20%) and prematurity without retinopathy of prematurity as the only cause (4%).
CONCLUSIONS: In this study, we provide the prevalence of infantile nystagmus based on national medical records in which all residents are accounted for. Our findings show a prevalence of 6.1 per 10 000 live births but six times higher among children born preterm than born at term. Ocular disease was the leading cause of infantile nystagmus with albinism and ocular malformations as the most frequent. In 1/3 of patients, no cause could be identified.
© 2020 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  albinism; congenital nystagmus; idiopathic infantile nystagmus; infantile nystagmus; paediatric ophthalmology

Year:  2020        PMID: 32067411     DOI: 10.1111/aos.14354

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  6 in total

1.  Genotypic and Phenotypic Spectrum of Foveal Hypoplasia: A Multicenter Study.

Authors:  Helen J Kuht; Gail D E Maconachie; Jinu Han; Line Kessel; Maria M van Genderen; Rebecca J McLean; Michael Hisaund; Zhanhan Tu; Richard W Hertle; Karen Gronskov; Dayong Bai; Aihua Wei; Wei Li; Yonghong Jiao; Vasily Smirnov; Jae-Hwan Choi; Martin D Tobin; Viral Sheth; Ravi Purohit; Basu Dawar; Ayesha Girach; Sasha Strul; Laura May; Fred K Chen; Rachael C Heath Jeffery; Abdullah Aamir; Ronaldo Sano; Jing Jin; Brian P Brooks; Susanne Kohl; Benoit Arveiler; Lluis Montoliu; Elizabeth C Engle; Frank A Proudlock; Garima Nishad; Prateek Pani; Girish Varma; Irene Gottlob; Mervyn G Thomas
Journal:  Ophthalmology       Date:  2022-02-11       Impact factor: 14.277

2.  Saccadic intrusions in pediatric non-accidental trauma.

Authors:  Xi Dai; Edward Kuwera
Journal:  Am J Ophthalmol Case Rep       Date:  2022-05-02

3.  Clinical utility gene card for FRMD7-related infantile nystagmus.

Authors:  Basu Dawar; Helen J Kuht; Jinu Han; Gail D E Maconachie; Mervyn G Thomas
Journal:  Eur J Hum Genet       Date:  2021-02-25       Impact factor: 5.351

4.  Discordant phenotypes in twins with infantile nystagmus.

Authors:  Abdullah Aamir; Helen J Kuht; Rebecca J McLean; Gail D E Maconachie; Viral Sheth; Basu Dawar; Ravi Purohit; Nicolas Sylvius; Michael Hisaund; Alina Zubcov-Iwantscheff; Frank A Proudlock; Irene Gottlob; Mervyn G Thomas
Journal:  Sci Rep       Date:  2021-02-02       Impact factor: 4.379

5.  Reply to "the spectrum of neuro-ophthalmologic involvement in mitochondrial disorders is broad".

Authors:  Jane H Lock; Neha K Irani; Nancy J Newman
Journal:  Taiwan J Ophthalmol       Date:  2021-07-16

6.  Aggressive Posterior Retinopathy of Prematurity: Long-Term Outcomes Following Intravitreal Bevacizumab.

Authors:  Ameay V Naravane; Peter J Belin; Shaina Rubino; Polly A Quiram
Journal:  Front Pediatr       Date:  2022-02-11       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.